← Back to signals
ORKA
Oruka Therapeutics, Inc.
Research: Finviz ↗·Perplexity ↗
No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.
Days to cover (short int.)
7.1d↓-16.9%
as of 2026-10-30 · shares short vs 2026-09-30
Fund 13D/13G Filings (2)
Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).
| Fund | Form | ∆ Shares | % of Class | Since Filing | Filed | Src |
|---|---|---|---|---|---|---|
| Viking Global | SC 13G/A | −1.2M | 2.5% | -3.2% vs SPY -5.5% abs | 2026-08-14 | ↗ |
| Viking Global | SC 13G/A | — | 5.3% | +69.1% vs SPY +74.6% abs | 2026-05-15 | ↗ |